Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
This Healthcare Stock Disappointed Investors. Here's Why It's Still a Buy.
06:00am, Wednesday, 09'th Nov 2022
AbbVie's strong portfolio has what it takes to drive long-term growth.
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
07:45am, Tuesday, 08'th Nov 2022
Just because the stock market is going haywire doesn't mean you have to sit on the sidelines.
3 No-Brainer Dividend Stocks to Buy in November
09:31am, Saturday, 05'th Nov 2022
There's no need for agonizing decision-making with these great dividend stocks.
3 Reasons to Buy AbbVie Stock Right Now
09:23am, Saturday, 05'th Nov 2022
The drugmaker has something to offer to all kinds of investors.
3 Dividend Kings Crushing the S&P 500 in 2022
04:33pm, Friday, 04'th Nov 2022
Companies in the Dividend King club carry well-established and successful business operations, clearly displayed by their commendable commitment to shareholders over decades of increased dividend payo
Better Buy: AbbVie vs. Walgreens Boots Alliance
08:15am, Friday, 04'th Nov 2022
Both these companies pay a dividend, but the similarities stop there.
Why Dividend Investors Can Still Buy AbbVie Stock With No Worries
05:52am, Thursday, 03'rd Nov 2022
The big-pharma company's dividend remains safe and sound.
5 Stocks to Watch on Recent Dividend Hikes Amid High Volatility
10:33am, Wednesday, 02'nd Nov 2022
Investors may keep a tab on ABBV, ASTE, BCC, ESQ and HIG, which have lately hiked their dividend payments to reward investors.
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 01'st Nov 2022
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
These 2 Passive Income Stars Just Declared Dividend Raises
08:45am, Tuesday, 01'st Nov 2022
It's been a good year for these two titans in their respective sectors -- hence the generosity.
Deal Activity Could Jumpstart Biotechnology
11:35pm, Monday, 31'st Oct 2022
Recent clinical successes and M&A could bring interest back to biotechnology, especially among mid-capitalization names with derisked or approved products. Restructuring, corporate activity, and COVID
Why is AbbVie Stock Falling, but Still Good Long-Term?
01:00am, Monday, 31'st Oct 2022
Why is AbbVie stock dropping today but still a solid investment? Its solid base, robust pipeline and dividend support a long position in ABBV stock.
Exxon Mobil, AbbVie, and Visa Raised Dividends
07:00am, Saturday, 29'th Oct 2022
Energy giant Exxon Mobil, pharmaceutical firm AbbVie, and cards firm Visa were among the U.S. companies that announced dividend increases last week.
AbbVie's Botox faces demand issues as prices soar
06:00pm, Friday, 28'th Oct 2022
Health care reporter Anjalee Khemlani outlines how inflation and supply and demand issues are putting the squeeze on AbbVie's Botox treatments.
AbbVie - 5 Aspects Of Q3 Earnings Persuading Me To "Buy The Dip"
05:55pm, Friday, 28'th Oct 2022
AbbVie released its Q322 earnings today. Revenue of $14.8bn slightly missed analysts expectations. Earnings per share increased by 24% on a diluted basis and 29% on an adjusted basis however.
